Channelopathies: Drug Interactions and Clinical Advances
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Drug Discovery, Development and Delivery".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 29
Special Issue Editor
Special Issue Information
Dear Colleagues,
Ion channels are fundamental to cellular function, and mutations in channel genes—known as channelopathies—underlie a wide range of neurological, cardiac, and muscular disorders. Understanding how drugs interact with these channels, both in their native and mutated forms, offers valuable insights into disease mechanisms and presents exciting opportunities for therapeutic advancement.
This Special Issue of Biomedicines aims to bring together original research and comprehensive reviews that explore the molecular, pharmacological, and clinical dimensions of channelopathies. We are particularly interested in studies demonstrating how drugs modulate ion channel behavior in the context of pathogenic mutations and how such findings may translate into better diagnostics, targeted therapies, or personalized medicine approaches.
We invite scientists and clinicians in neurophysiology, cardiology, pharmacology, and related fields to contribute to this Special Issue as it is a great opportunity to increase research visibility within a dynamic interdisciplinary community. Whether your work is experimental, computational, or clinically focused, your contribution can help shape the future of channelopathy research and patient care.
We look forward to receiving your valuable submissions and to building a collection that reflects the vibrant progress and collaborative spirit of this field.
Dr. Cesar Celis Ceballos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- electrophysiology
- ion channels
- channelopathies
- drugs
- patch-clamp
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
